The loss of thyroid clinical knowledge from Werner & Ingbar’s The Thyroid

Decades ago, a lot more doctors knew how thyroid hormone levels influenced all organs and tissues’ health. It wasn’t all about the influence of thyroid hormones on the TSH. It was more about the influence of truly adequate thyroid hormone levels on real health outcomes. A lot more doctors learned and understood that if thyroid …

Continue reading The loss of thyroid clinical knowledge from Werner & Ingbar’s The Thyroid

2014 ATA therapy guidelines: 5. Research

This post continues my series of paraphrases of Jonklaas et al's 2014 guidelines that I left unfinished weeks ago. Here I provide paraphrases and quotations of what they set forth for the "ethics" of research in thyroid therapy in Section 18, and what they recommend as topics for future research in thyroid therapy. I provide …

Continue reading 2014 ATA therapy guidelines: 5. Research

Dr. Ron Matsusaki’s license to treat thyroid suspended April 17, 2019

One of Canada's best thyroid doctors, Dr. Ron Matsusaki in Nova Scotia, has had his license to prescribe and treat thyroid suspended. His thyroid clinic in Digby has been under review for the past month, and the decision was announced on the clinic's Facebook group April 17, 2019.(1) Let's do everything we can to speak …

Continue reading Dr. Ron Matsusaki’s license to treat thyroid suspended April 17, 2019

CSEM attempts to dialogue with thyroid patients, April 8, 2019

In my previous post, I discussed the statement of the Canadian Society of Endocrinology and Metabolism (CSEM) response to thyroid patients' concerns, dated April 8th, 2019. There, I showed that the minor edit of adding a clause about central hypothyroidism is not really an update to the guidelines, which already acknowledged this exception. The document …

Continue reading CSEM attempts to dialogue with thyroid patients, April 8, 2019

CSEM’s edit to FT3 and FT4 testing prohibitions, April 8, 2019

On April 8, 2018 The Canadian Society for Endocrinology and Metabolism (CSEM) made the happy announcement that they have made an edit to their prohibition of FT3 and FT4 testing in hypothyroidism. At first, patients were elated, hopeful, feeling like they were finally being heard! Maybe the Canadian Thyroid Foundation said something to open the …

Continue reading CSEM’s edit to FT3 and FT4 testing prohibitions, April 8, 2019

Endocrinology network news reviews study on T3-based therapy prescribing

Good post on "Endocrinology Network" news, summarizing of research and trends regarding T3-based thyroid medication prescriptions for hypothyroidism around the world (not mentioning Canada, though). Fuerst, M. (2019, February 14). Physician–patient interaction may influence prescribing patterns in hypothyroidism | Endocrinology Network. Retrieved February 25, 2019, from http://www.endocrinologynetwork.com/thyroid-disorders/physicianpatient-interaction-may-influence-prescribing-patterns-hypothyroidism Apparently, In the United States, in 2017, “approximately …

Continue reading Endocrinology network news reviews study on T3-based therapy prescribing

Shomon: Why endocrinologists may oppose desiccated thyroid therapy

An article by Mary Shomon, updated Dec, 2018, explains why endocrinologists are biased against desiccated thyroid. Fogoros, R. N., & MD. (n.d.). Why Your Endocrinologist May Oppose Natural Thyroid. Retrieved January 5, 2019, from https://www.verywellhealth.com/why-endocrinologists-oppose-natural-thyroid-3882628  Ultimately, it comes down to endocrinologists preferring to Trust the Pituitary more than the rest of your body. Mary Shomon …

Continue reading Shomon: Why endocrinologists may oppose desiccated thyroid therapy